Mailroom Scanners
PRODUCTS
-
The QPM0106 is a packaged, high-power amplifier fabricated on Qorvo's production 0.25 um GaN on SiC process that operates from 1.0 - 6.0 GHz and provides 45.4 dBm (35 W) of saturated output power.
-
The AMP2030B-LC is engineered for broadband EMI/RFI testing, laboratory use, GTEM cell applications, and IEC compliance testing.
-
Effortlessly distribute, monitor, and exchange study documents with every site—wherever they work, whenever they need it.
Other tools promise site connections, but they can't deliver 100% coverage with a solution sites actually want.
Adoption
They claim sites use their tool…but you need sites to love it.
Tracking
They let you send documents…but you need to know the status of every document at every site.
Integration
They offer integration within their ecosystem…but you need compatibility with every site and sponsor software.
-
Our RegOps team offers document-level publishing or management of the entire regulatory submission process. Coupled with our electronic document management system (Veeva), we can oversee all technical aspects for submission of your dossier (eg, eCTD document granularity, utilization of content templates, document formatting, hyperlinking, bookmarks, navigation, publishing, and redaction services).
-
Change how you compete by getting the clinical data services and support you need. Medrio is here to help clinical trial sponsors and CROs build internal expertise and support any clinical trial data management needs.
WHITE PAPERS AND CASE STUDIES
-
3 Themes And Takeaways From FDA's Draft Guidance On DCTs
Get our experts’ summary of recent regulatory guidance as well as recommendations for optimal decentralized clinical trial design and conduct.
-
Non-Viral Genetic Modification Using The 4D-Nucleofector LV Unit In CGT
This paper underscores the 4D-Nucleofector® LV Unit as a pivotal tool for translating genetic modification technologies into scalable, safe, and effective therapeutic solutions.
-
Analytics–Powered Approach To Patient Recruitment Strategy
In a Phase 3 psychiatry trial, a pharmaceutical company partnered with Signant to revolutionize patient recruitment through data-driven site selection using PureSignal Analytics.
-
A Feeder-Free Platform For Generating Mature Natural Killer Cells
NK cells represent a promising avenue for immunotherapy. Examine the advantages of NK cells in cellular immunotherapy and the importance of developing efficient activation and expansion platforms.
-
Expanding The OSD Toolbox: An Industry Approach To Adsorb Lipids Onto Powder Substrates
Explore innovative solutions for improving the solubility and bioavailability of poorly soluble compounds in solid oral dosage forms to enhance drug delivery and therapeutic effectiveness.
-
Industrial Smart Components: What To Use When
The objective of this paper is to provide an overview of the current standard industrial HID Global RFID tag portfolio and provide a guideline of the RFID tag family’s main propositions.
-
Membrane Adsorber Chromatography In Oligo-mAb Conjugation
Discover how the team was able to expedite the conjugation of an oligonucleotide-monoclonal antibody (oligo-mAb) program leveraging experience in chromatography.
-
A Strategic Guide For Biotech And Biopharma Leaders
Securing drug approval is a complex, high-stakes process, and outdated review workflows hinder progress. Explore modern solutions that accelerate timelines without compromising compliance or quality.
-
Labware Washing Techniques And The Sinner's Circle
Explore labware cleaning techniques, comparing manual and automated processes, and how balancing the four factors of the Sinner’s Circle ensures effective, repeatable laboratory outcomes.
-
Pasteurized Equivalent Water For AgriMark-Cabot Dairy In Vermont
Discover how AgriMark-Cabot Dairy transformed wastewater into a valuable resource using UV technology, achieving significant energy and water savings while maintaining stringent food safety standards.
-
What Is A "Smart" Amplifier?
Recent advancements in amplifier design provide substantial improvements in terms of both flexibility and efficiency, creating a new class of "smart amplifiers."
-
Material Selection For Medical Device Manufacturability
Choosing the right material in the earliest stages of research & development can make all the difference in beating your competitors to market and avoid increased project costs, development delays and manufacturing setbacks.
NEWS
-
Siemens Receives Frost & Sullivan's 2025 Europe, Middle East, And Africa Company Of The Year Award For Excellence In Smart Water Meter Data Management7/1/2025
Frost & Sullivan is pleased to announce that Siemens has been awarded the 2025 Europe, Middle East, and Africa Company of the Year Award in the smart water meter data management (MDM) industry for its outstanding achievements in digital innovation, operational efficiency, and customer impact. This recognition highlights Siemens's leadership in delivering intelligent, scalable, and vendor-agnostic water MDM solutions that help utilities optimize operations, engage customers, and support long-term sustainability.
-
Novotech Honored With Frost & Sullivan's 2024 Best Practices Company Of The Year Award For Leadership In Biotech CRO Services9/10/2024
Novotech, the global full-service clinical Contract Research Organization (CRO), is proud to announce that it has been awarded the prestigious 2024 Global Company of the Year Award by Frost & Sullivan. This recognition underscores Novotech’s commitment to accelerating clinical development for biotech companies through innovative solutions, advanced analytics, and a comprehensive global reach.
-
LogicalDOC 9.2.1 Now Available With Enhanced AI And Security Features10/7/2025
LogicalDOC, a leading provider of enterprise document management solutions, is proud to announce the release of LogicalDOC 9.2.1, a major update designed to deliver enhanced AI capabilities, stronger security, and even greater efficiency for organizations worldwide.
-
AbTherx And Dragonfly Therapeutics Expand Antibody Discovery Partnership9/23/2025
AbTherx, a biotechnology company pioneering technologies that accelerate antibody discovery, today announced an expansion of its ongoing partnership with Dragonfly Therapeutics (Dragonfly) following a successful multi-target pilot study comparing transgenic platforms.